| Literature DB >> 34821183 |
Abstract
Bangladesh showed initial success in the mass inoculation drive. However, the program was going through an alarming situation when the serum institute of India halted the shipments. Now the authority is administering US Moderna vaccines, Chinese Sinopharm vaccines, and Pfizer vaccines. Mass immunization is the only way for Bangladesh besides the present COVID-19 responses. Therefore, Bangladesh can utilize its previous experience in the roll-out of mass vaccination. The country can search for all available alternatives of COVID-19 vaccines besides maintaining diplomatic consistency with the existing sources for early vaccination of its population. The authority can try to get the committed vaccines from the COVAX program. Also, the country needs to maintain diplomatic relations with other global alliances that are promising support to poor and developing countries for the COVID-19 vaccine. The government can also consider direct purchases from vaccine manufacturers.Entities:
Keywords: Bangladesh; Covid-19; Southeast Asia; mass immunization; vaccine
Mesh:
Substances:
Year: 2021 PMID: 34821183 DOI: 10.1177/00368504211058562
Source DB: PubMed Journal: Sci Prog ISSN: 0036-8504 Impact factor: 2.774